I've thought very carefully about ‘going public’ with this, because it's a sensitive argument to make, especially in the face of so many young people struggling.
(cont 🧵)
tinyurl.com/vun92cz7
I've thought very carefully about ‘going public’ with this, because it's a sensitive argument to make, especially in the face of so many young people struggling.
(cont 🧵)
tinyurl.com/vun92cz7
We’re delighted to have @mark-toshner.bsky.social joining #DDDS2025, who will be speaking on 'How to define or prove disease modification'.
We’re delighted to have @mark-toshner.bsky.social joining #DDDS2025, who will be speaking on 'How to define or prove disease modification'.
Thanks to our speakers and attendees!
#HLRI #MetabolicHealth #VascularInflammation @cambridgeuni.bsky.social
@murrayclarkelab.bsky.social
Thanks to our speakers and attendees!
#HLRI #MetabolicHealth #VascularInflammation @cambridgeuni.bsky.social
@murrayclarkelab.bsky.social
t.co/q7Uyg8uRdJ
t.co/q7Uyg8uRdJ
t.co/q7Uyg8uRdJ
t.co/q7Uyg8uRdJ
publications.ersnet.org/content/erjo...
@charlottesummers.bsky.social @mark-toshner.bsky.social @lukeflower.bsky.social
publications.ersnet.org/content/erjo...
@charlottesummers.bsky.social @mark-toshner.bsky.social @lukeflower.bsky.social